203 related articles for article (PubMed ID: 30519330)
1. Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis.
Kim JH; Kim HS; Kim BJ; Han B; Choi DR; Kwon JH
J Cancer; 2018; 9(22):4279-4286. PubMed ID: 30519330
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Qian HH; Xu TS; Cai XQ; Ji TL; Guo HX
Clin Chim Acta; 2015 Dec; 451(Pt B):208-14. PubMed ID: 25661085
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis.
Kim JH; Kim HS; Kim BJ
J Cancer; 2018; 9(10):1836-1845. PubMed ID: 29805710
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival.
Haque AK; Syed S; Lele SM; Freeman DH; Adegboyega PA
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):103-9. PubMed ID: 12051626
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
Wang Y; Wu Y; Li J; Li J; Che G
Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
[TBL] [Abstract][Full Text] [Related]
6. Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.
Berghmans T; Paesmans M; Mascaux C; Martin B; Meert AP; Haller A; Lafitte JJ; Sculier JP
Ann Oncol; 2006 Nov; 17(11):1673-6. PubMed ID: 16980598
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review.
Kim BJ; Kim JH; Kim HS
Oncotarget; 2017 Aug; 8(31):51779-51785. PubMed ID: 28881686
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
Myong NH
J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
[TBL] [Abstract][Full Text] [Related]
10. The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
Liu L; Shao X; Gao W; Bai J; Wang R; Huang P; Yin Y; Liu P; Shu Y
J Thorac Oncol; 2010 Dec; 5(12):1922-32. PubMed ID: 21155183
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review.
Zhang J; Wang S; Wang L; Wang R; Chen S; Pan B; Sun Y; Chen H
Onco Targets Ther; 2015; 8():3361-9. PubMed ID: 26604794
[TBL] [Abstract][Full Text] [Related]
12. The association of melanoma-associated antigen-A gene expression with clinicopathological characteristics and prognosis in resected non-small-cell lung cancer: a meta-analysis.
Wang Y; Lu Y; Li J; Wu Y; Che G
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):855-860. PubMed ID: 31384932
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
Deng XF; Liu QX; Zhou D; Min JX; Dai JG
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Meng D; Yuan M; Li X; Chen L; Yang J; Zhao X; Ma W; Xin J
Lung Cancer; 2013 Jul; 81(1):1-10. PubMed ID: 23608713
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations.
Park JY; Jang SH; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Seo J; Lee CY; Ko Y; Park YB
BMC Cancer; 2019 Jun; 19(1):574. PubMed ID: 31196060
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Zhu L; Yu H; Liu SY; Xiao XS; Dong WH; Chen YN; Xu W; Zhu T
PLoS One; 2015; 10(4):e0124230. PubMed ID: 25905787
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of estrogen receptor beta protein but not mRNA predicts poor prognosis and may be associated with enhanced translation in non-small cell lung cancer: a systematic review and meta-analysis.
Meng W; Liao Y; Chen J; Wang Y; Meng Y; Li K; Xiao H
J Thorac Dis; 2021 Jul; 13(7):4281-4300. PubMed ID: 34422356
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of oligometastatic non-small cell lung cancer: a meta-analysis.
Li S; Zhu R; Li D; Li N; Zhu X
J Thorac Dis; 2018 Jun; 10(6):3701-3713. PubMed ID: 30069368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
